Great Plains Health seeing success with drug treating COVID-19

Aviptadil drug to help lungs
Published: Nov. 13, 2020 at 6:46 PM CST
Email This Link
Share on Pinterest
Share on LinkedIn

NORTH PLATTE, Neb. (KNOP) - Infection Disease Physician, Dr. Freitas, and his team of physicians, pharmacists and nurses are doing research in data collection and safe monintoring to ensure the drug Aviptadil can help patients with severe cases of COVID recover more quickly.

Aviptadil has been studied for other lung diseases. It moderates inflammation in the lung. COVID causes inflammatory response and this medication is reserved to be used for severe cases of respiratory failure. Dr. Freitas says they are still researching and have used it on 14 patients in North Platte. He says the patients thus far have tolerated it well. Aviptadil requires A 12-hour infusion to give the medication. 58-year-old COVID-19 survivor Mike Cardenas had no underlying health conditions. He says he is thankful he got the care he needed during his three week span on hospitalization, and for this the drug helped him breathe.

Cardenas asks the community to continue to listen to the health experts and to listen to the doctors if you are suffering from COVID-19.

Dr. Freitas says they plan to continue the research of Aviptadil and hope to have more information by the end of the year.

Copyright 2020 KNOP. All rights reserved.